Clinical Trials Logo
  1. Home
  2. Ventricular Septal Defect
  3. NCT04017975

Optical Tissue Identification for Myocardial Architecture — OPTIMA  

Ventricular Septal Defect Clinical Trial

Official title:
Optical Tissue Identification for Myocardial Architecture (OPTIMA Study)

Clinical Trial Summary

The goal of this study is to test the hypothesis that fiberoptic confocal microscopy (FCM) imaging during repair of common congenital heart defects is a useful adjunct for avoidance of conduction abnormalities.

Clinical Trial Description

This is an interventional randomized controlled study to investigate the use of fiberoptic confocal microscopy (FCM) imaging for avoidance of conduction abnormalities during repair of common congenital heart defects. Study results will be compared to a cohort of similar surgical patients following standard surgical procedures where FCM was not used. We will analyze pre-and postoperative ECGs to identify conduction abnormalities. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04017975
Study type Interventional
Source Boston Children's Hospital
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 20, 2019
Completion date September 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03684161 - Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Completed NCT01120964 - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Phase 1/Phase 2
Completed NCT02914652 - The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. Phase 4
Recruiting NCT05939713 - Cera™ VSD Occluder Post Market Clinical Follow-up
Recruiting NCT06298344 - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease Early Phase 1
Recruiting NCT05688670 - Regional Anesthesia Following Pediatric Cardiac Surgery Phase 4
Completed NCT02138435 - Longterm Outcome After Ventricular Septal Defect Closure N/A
Recruiting NCT05253209 - A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects Phase 3
Completed NCT00556361 - Use of Ketamine Prior to Cardiopulmonary Bypass in Children Phase 2
Completed NCT05200910 - The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
Recruiting NCT03127748 - Cardiac Function After Transcatheter VSD Closure N/A
Enrolling by invitation NCT06214182 - Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
Active, not recruiting NCT04667455 - Improving Care for Children With Congenital Heart Disease. N/A
Completed NCT04417712 - Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
Completed NCT01313832 - The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension N/A
Completed NCT01915277 - A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics Phase 1
Recruiting NCT03941691 - A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure N/A
Completed NCT04859036 - The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters